Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23118
Gene Symbol: TAB2
TAB2
0.100 Biomarker disease HPO
Entrez Id: 50484
Gene Symbol: RRM2B
RRM2B
0.100 Biomarker disease HPO
Entrez Id: 51086
Gene Symbol: TNNI3K
TNNI3K
0.100 Biomarker disease HPO
Entrez Id: 2353
Gene Symbol: FOS
FOS
0.100 Biomarker disease HPO
Entrez Id: 5428
Gene Symbol: POLG
POLG
0.100 Biomarker disease HPO
Entrez Id: 291
Gene Symbol: SLC25A4
SLC25A4
0.100 Biomarker disease HPO
Entrez Id: 284119
Gene Symbol: CAVIN1
CAVIN1
0.100 Biomarker disease HPO
Entrez Id: 26580
Gene Symbol: BSCL2
BSCL2
0.100 Biomarker disease HPO
Entrez Id: 79188
Gene Symbol: TMEM43
TMEM43
0.100 Biomarker disease HPO
Entrez Id: 56652
Gene Symbol: TWNK
TWNK
0.100 Biomarker disease HPO
Entrez Id: 1837
Gene Symbol: DTNA
DTNA
0.100 Biomarker disease HPO
Entrez Id: 10555
Gene Symbol: AGPAT2
AGPAT2
0.100 Biomarker disease HPO
Entrez Id: 7504
Gene Symbol: XK
XK
0.100 Biomarker disease HPO
Entrez Id: 781
Gene Symbol: CACNA2D1
CACNA2D1
0.100 Biomarker disease HPO
Entrez Id: 2152
Gene Symbol: F3
F3
0.080 Biomarker disease BEFREE The most prominent mutation hot spot was also the most prominent hot spot for adduct formation as judged by the frequency of termination of in vitro polymerization by the Klenow fragment on N-AcO-TFA-AF-treated plasmids. 2591021 1989
Entrez Id: 3360
Gene Symbol: HTR4
HTR4
0.320 Therapeutic disease CTD_human Do human atrial 5-HT4 receptors mediate arrhythmias? 7886817 1994
Entrez Id: 5350
Gene Symbol: PLN
PLN
0.450 AlteredExpression disease BEFREE Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. 10193721 1999
Entrez Id: 4879
Gene Symbol: NPPB
NPPB
0.370 AlteredExpression disease BEFREE Persistent AF was associated with higher mRNA expression of pro-BNP (+66%, P = 0.04, in patients without valvular disease, and +69%, P < 0.01, in patients with valvular disease) and lower mRNA expression of NPR-A (-58%, P = 0.02, in patients without valvular disease, and -62 %, P < 0.01, in patients with valvular disease). 10376920 1999
Entrez Id: 3784
Gene Symbol: KCNQ1
KCNQ1
0.200 Biomarker disease BEFREE We found that the mRNA levels of KV1.5, HERG and KVLQT1 were all significantly decreased in patients with persistent atrial fibrillation for more than 3 months. 10844385 1999
Entrez Id: 57419
Gene Symbol: SLC24A3
SLC24A3
0.010 AlteredExpression disease BEFREE Sarcoplasmic reticulum calcium ATPase, phospholamban and sodium-calcium exchanger mRNA contents were not affected by AF. 10355697 1999
Entrez Id: 3107
Gene Symbol: HLA-C
HLA-C
0.010 GeneticVariation disease BEFREE We report that the beta-MHC missense mutation Arg663His causes predominant cardiac morphology and atrial fibrillation. 10750581 1999
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.400 Biomarker disease BEFREE An ACE-dependent increase in the amounts of activated Erk1/Erk2 in atrial interstitial cells may contribute as a molecular mechanism for the development of atrial fibrosis in patients with AF. 10807475 2000
Entrez Id: 183
Gene Symbol: AGT
AGT
0.100 AlteredExpression disease BEFREE The purpose of this study was to determine the atrial expression of angiotensin II type 1 and type 2 receptors (AT(1)-R and AT(2)-R) in patients with AF. 10851203 2000
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.060 Biomarker disease BEFREE The amount of AT(1)-R was reduced to 34.9% during cAF (P<0.01) and to 51.7% during pAF (P<0.05) compared with patients in sinus rhythm. 10851203 2000
Entrez Id: 5595
Gene Symbol: MAPK3
MAPK3
0.040 AlteredExpression disease BEFREE An ACE-dependent increase in the amounts of activated Erk1/Erk2 in atrial interstitial cells may contribute as a molecular mechanism for the development of atrial fibrosis in patients with AF. 10807475 2000